Expression of protease-activated receptor-2 in human gastric stromal tumor and its clinicopathological significance

Hepatogastroenterology. 2013 Nov-Dec;60(128):2125-8. doi: 10.5754/hge13467.

Abstract

Background/aims: To explore the expression of protein-activated receptor-2 (PAR-2) in human gastric stromal tumor and its clinicopathological significance.

Methodology: The expression of PAR-2 was detected with immunohistochemisty, RT-PCR and Western blot in tumor tissue, peritumoral tissue and gastric normal tissue from 72 patients with gastric stromal tumor.

Results: PAR-2 expression was significantly higher in peritumoral tissue (p < 0.05) and tumor tissue (p < 0.01) than in gastric normal tissue, and significantly higher in tumor tissue than in peritumoral tissue (p < 0.01). With the increase in NIH grade, PAR-2 expression was elevated in tumor tissues. PAR-2 expression was strongly associated with mucosal invasion.

Conclusions: PAR-2 expression is significantly higher in gastric stromal tumor tissue than in peritumoral tissue and gastric normal tissue. The high expression of PAR-2 may be associated with the invasion and metastasis of gastric stromal tumor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Biomarkers, Tumor / analysis*
  • Biomarkers, Tumor / genetics
  • Blotting, Western
  • Female
  • Gastrointestinal Stromal Tumors / chemistry*
  • Gastrointestinal Stromal Tumors / genetics
  • Gastrointestinal Stromal Tumors / secondary
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Neoplasm Grading
  • Neoplasm Invasiveness
  • RNA, Messenger / analysis
  • Receptor, PAR-2 / analysis*
  • Receptor, PAR-2 / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Stomach Neoplasms / chemistry*
  • Stomach Neoplasms / genetics
  • Stomach Neoplasms / pathology
  • Up-Regulation

Substances

  • Biomarkers, Tumor
  • RNA, Messenger
  • Receptor, PAR-2